SavedAdd your journal

Journals / Turkish Journal of Veterinary and Animal Sciences / 2019 / Cilt: 43 - Sayı: 2

Assessment of asymmetric dimethyl arginine, cardiac troponin I, thyroxine, cholesterol, and triglyceride levels in obese dogs and dogs with normal body condition

Hüseyin CİHAN
Merve TURAL
Pages
271–275
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is thought that the findings of this study may help future studies in determiningnovel biomarkers for obesity in dogs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to assess serum asymmetric dimethyl arginine (ADMA), cardiac troponin I (cTnI), thyroxine (T4),cholesterol and triglyceride (TG) levels in dogs with normal body condition and obese dogs.
📊
Key Findings & Data:A total of 40 dogs (n = 40) were includedin the study and dogs were divided into two groups; 20 dogs with normal body condition and 20 obese dogs.
💡
Conclusion & Impact:It is thought that the findings of this study may help future studies in determiningnovel biomarkers for obesity in dogs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this study was to assess serum asymmetric dimethyl arginine (ADMA), cardiac troponin I (cTnI), thyroxine (T4),cholesterol and triglyceride (TG) levels in dogs with normal body condition and obese dogs. A total of 40 dogs (n = 40) were includedin the study and dogs were divided into two groups; 20 dogs with normal body condition and 20 obese dogs. The dogs were groupedaccording to the five-point body-condition scoring (BCS) system. Serum ADMA, cTnI, T4, cholesterol, and TG levels were measuredin addition to routine biochemical parameters. Serum ADMA, cTnI, TG, and cholesterol levels were statistically significant betweenthe two groups (P < 0.001, P < 0.001, P = 0.027, P = 0.006, respectively). There was a positive correlation between the serum cholesterollevels and both TG and cTnI levels among obese dogs. It is thought that the findings of this study may help future studies in determiningnovel biomarkers for obesity in dogs.

🔖

Cite This Article

CİHAN, H., TURAL, M. (2022). Assessment of asymmetric dimethyl arginine, cardiac troponin I, thyroxine, cholesterol, and triglyceride levels in obese dogs and dogs with normal body condition. Turkish Journal of Veterinary and Animal Sciences, Cilt: 43 - Sayı: 2, 271–275. https://ajindex.com/articles/614894

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Hamper B. Current topics in canine and feline obesity. Veterinary Clinics of North America Small Animal Practice 2016; 46 (5): 785-795. doi: 10.1016/j.cvsm.2016.04.003 2. Chandler M, Cunningham S, Lund EM, Khanna C, Naramore R et al. Obesity and associated comorbidities in people and companion animals: A one health perspective. Journal of Comparative Pathology 2017; 156 (4): 296-309. doi: 10.1016/j. jcpa.2017.03.006 3. Kirk CA. Preventing obesity in dogs and cats. In: Proceedings of the World Small Animal Veterinary Association World Congress; Jeju, Korea; 2011. pp. 11-14. 4. Laflamme DP. Companion Animals Symposium: Obesity in dogs and cats: What is wrong with being fat? Journal of Animal Science 2012; 90 (5): 1653-1662. doi::10.2527/jas2011-4571 5. Bray GA. Classification and evaluation of the overweight patient. In: Bray G, Bouchard C, editors. Handbook of Obesity. 2nd ed. New York, NY, USA: Marcel Dekker Inc.; 2003. pp. 631-654. 6. Sanderson S. Obesity: health & mobility risks. In: Proceeding of the 83rd Annual Western Veterinary Conference; Las Vegas, NV, USA; 2011. pp. 1-8. 7. Montoya-Alonso JA. Canine obesity. In: Proceedings of the Southern European Veterinary Conference & Congreso Nacional AVEPA; Barcelona, Spain; 2008. pp. 9-13. 8. Flanagan J, Bissot T, Hours MA, Moreno B, FeugierA et al. Success of a weight loss plan for overweight dogs: the results of an international weight loss study. PLoS ONE 2017; 12 (9): e0184199. doi: 10.1371/journal.pone.0184199 9. Williams IL, Wheatcroft SB, Shah AM, Kearney MT. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans. International Journal of Obesity and Related Metabolic Disorders 2002; 26 (6): 754-764. doi: 10.1038/sj.ijo.0801995 10. Buğdaycı G, Serin E. Asymmetrical dimethylarginine (ADMA). Düzce Tıp Fakültesi Dergisi 2005; 2: 36-41 (article in Turkish with an English abstract). 11. Aydın M, Erdoğmuş F, Armutçu F, Yiğitoğlu MR. Metabolism of asymmetric dimethyl arginine (ADMA). International Journal of Basic and Clinical Medicine 2013; 1 (1): 61-66 (article in Turkish with an English abstract). 12. Krzyzanowska K, Mittermayer F, Kopp HP, Wolzt M, Schernthaner G. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. The Journal of Clinical Endocrinology & Metabolism 2004; 89 (12): 6277-6281. doi: 10.1210/jc.2004-0672 13. Sleeper MM, Clifford CA, Laster LL. Cardiac troponin I in the nor